Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe - BNN Bloomberg
Does Teva's $15M, 18-year opioid settlement with Louisiana signal the start of a trend? | Fierce Pharma
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva enters opioid settlement agreement with US state Rhode Island
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva Settles Price-Fixing-Related Securities Class Action Litigation for $420 Million | The D&O Diary
Is 2019 The Trough For Teva, Or Will 2020 Continue To See Pressure? (NYSE: TEVA) | Seeking Alpha
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT IN RE TEVA SECURITIES LITIGATION : No. 3:17-cv-00558 (SRU) LONG-FORM NO
Teva Settles Price-Fixing-Related Securities Class Action Litigation for $420 Million | The D&O Diary
Teva settles investor lawsuit for $420m - Globes
If you bought Provigilo directly from Cephalon, you could get a
Purdue Pharma, others could deduct opioid settlements from taxes
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Rosen Law Firm Files Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA
Teva, Allergan Settle Opioid Lawsuit With West Virginia
Teva charged in US price-fixing investigation | Financial Times
Teva Pharmaceutical Industries Settles $420 Million Shareholder Lawsuit
Teva settles shareholder lawsuit over generic drug | Business Insurance
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA EMPLOYE
Teva settles investor lawsuit for $420m - Globes
Pfizer and Teva face new drug delay action - Global Competition Review
Teva Shareholder Notice
